Y-mAbs Therapeutics
YMAB
#6603
Rank
$0.51 B
Marketcap
$11.59
Share price
-12.06%
Change (1 day)
116.23%
Change (1 year)

Y-mAbs Therapeutics (YMAB) - Cash on Hand

Cash on Hand as of June 2024 : $77.8 Million USD

According to Y-mAbs Therapeutics 's latest financial reports the company has $77.8 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Y-mAbs Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$78.63 M-25.65%
2022-12-31$0.10 B-41.75%
2021-12-31$0.18 B58.39%
2020-12-31$0.11 B-44.66%
2019-12-31$0.20 B40.11%
2018-12-31$0.14 B63.39%
2017-12-31$90.48 M436.2%
2016-12-31$16.87 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.28 B 268.10%๐Ÿ‡บ๐Ÿ‡ธ USA